Applied Therapeutics Inc expected to post a loss of 31 cents a share - Earnings Preview

Applied Therapeutics

08/05/2023 19:34

* Applied Therapeutics Inc  APLT.OQ   APLT.O  is expected
to show
no change in quarterly revenue when it reports  results on May
10 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Applied
Therapeutics Inc
is for a loss of 31 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 3.5%
in the last three months. ​
    * Wall Street's median 12-month price target for Applied
Therapeutics Inc is $5​, above​ its last closing price of $1.58.
​​​

This summary was machine generated May 8 at 18:34 GMT.  All
figures in US dollars  unless otherwise stated